Ajanta Pharma Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Mpride V 1/0.3 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Mpride V 1/0.3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mpride V 1/0.3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Mpride V 1/0.3 Tablet SR.
Mpride V 1/0.3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Mpride V 1/0.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Mpride V 1/0.3 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Mpride V 1/0.3 Tablet SR contains a combination of three medicines: Glimepiride, Metformin and Voglibose. It's used to treat type 2 diabetes mellitus (DM). This medicine helps improve blood glucose levels in adults who take it along with proper diet and exercise. Glimepiride lowers blood sugar by increasing insulin release from the pancreas. Metformin works by reducing glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not intended for type 1 DM treatment.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Avoid use if you are allergic to the medication's components or excipients, have moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations or underlying metabolic acidosis including diabetic ketoacidosis.
No, Mpride V 1/0.3 Tablet SR and alcohol should not be taken together. This combination may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Mpride V 1/0.3 Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely if you miss meals, drink alcohol excessively, over-exercise, or take other antidiabetic medication alongside it. Regular blood sugar monitoring is important. Keep glucose tablets, honey, or fruit juice handy.
Store this medicine in its original packaging, tightly closed. Follow storage instructions on the pack or label. Dispose of unused medicine. Keep it out of reach of pets, children, and other people.